Thromboxane A2

From NuGOwiki

(Redirected from HMDB01452)
Jump to: navigation, search

The NuGOwiki Metabolite Database is a joint initiative of NuGO and HMDB

Taxonomy Navigation Box; search by

All Metabolites | Biochemical | Nutritional | Functional | Metabolic Pathways | Diseases | Phenotypes | Physiological Processes | Protein

Thromboxane A2
2D structure for Thromboxane A2
Chemical Name 7-[3-(3-hydroxyoct-1-enyl)-4,6-dioxabicyclo[3.1.1]hept-2-yl]hept-5-enoic acid
Chemical Formula C20H32O5
CAS Number 57576-52-0
Chemical Information HMDB01452
Biochemical Taxonomy

  • Prostanoids

Functional Taxonomy Not Available
Nutritional Taxonomy Not Available
Metabolic Pathways

  • Prostaglandin and Leukotriene Metabolism

Biofluid Location

  • Blood

Tissue Location

  • Smooth Muscle
  • Platelet

Normal Biofluid Concentrations

  • Blood: 0.00024 +/- 0.000036 uM

Normal Tissue Concentrations Not Available
Diseases / Conditions Related to Nutrition

  • Children with an inherited predisposition to coronary heart disease

Other (Monogenic Disorders) Not Available
Abnormal Biofluid Concentrations

  • Blood (Children with an inherited predisposition to coronary heart disease): 0.00045 +/- 0.000047 uM

Abnormal Tissue Concentrations Not Available
Physiological Processes Not Available
Authors:
Affiliations:

Contents

Introduction

guidelines
An unstable intermediate between the prostaglandin endoperoxides and thromboxane B2. The compound has a bicyclic oxaneoxetane structure. It is a potent inducer of platelet aggregation and causes vasoconstriction. It is the principal component of rabbit aorta contracting substance (RCS).

Biological Function

guidelines

Catabolism

guidelines

Diseases / Conditions Related to Nutrition

guidelines

  • Children with an inherited predisposition to coronary heart disease

Other (Monogenic) Disorders

guidelines


Nutritional Information

guidelines

Drivers for biological variation

guidelines

Vulnerable groups

guidelines

Other resources

guidelines

Links

guidelines